Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 2, 2000, Pages 561-567

  Miyajima Uchida, Hiroko ^a   Hayashi, Hideyuki ^b   Beppu, Richiko ^b   Kuroki, Motomu ^b   Fukami, Mitsue ^b   Arakawa, Fumiko ^b   Tomita, Yoshihiro ^b   Kuroki, Masahide ^b   Oshima, Kenji ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MESSENGER RNA; THROMBOSPONDIN 1;

ANGIOGENESIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; CELL COUNT; CELL DIVISION; CELLS, CULTURED; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; PIGMENT EPITHELIUM OF EYE; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOSPONDIN 1;

EID: 0033971666     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol. 1986;103: 1635-1648.
2. Lawler J. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim Biophys Acta. 1993; 1182:1-14.
3. Gantt SM, Clavijo P. Bai X, Esko JD, Sinnis P. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J Biol Chem. 1997;272:19205-19213.
4. Legrand C, Dubernard S, Rabhi-Sabile S, da Silva VM. Function and clinical significance of thrombospondin. Platelets. 1997;8:211-223.
5. Dawes J, Clemetson KJ, Gogstad GO, et al. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res. 1983;29:569-581.
6. Wencel Drake JD, Painter RG, Zimmerman TS, Ginsberg MH. Ultrastructural localization of human platelet thrombospondin. fibrinogen, fibronectin, and von Willebrand factor in frozen thin section. Blood. 1985;65:929-938.
7. Suzuki H, Katagiri Y, Tsukita S, Tanoue K, Yamazaki H. Localization of adhesive proteins in two newly subdivided zones in electron-lucent matrix of human platelet alpha-granules. Histochemistry. 1990;94:337-344.
8. Murphy Ullrich JE, Mosher DF. Localization of thrombospondin in clots formed in situ. Blood. 1985;66:1098-1104.
9. Watkins SC, Raso V, Slayter HS. Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation. Histochem J. 1990; 22:507-518.
10. Sage H, Crouch E, Bornstein P. Collagen synthesis by bovine aortic endothelial cells in culture. Biochemistry. 1979;18:5433-5442.
11. Lyons Giordano B, Brinker JM, Kefalides NA. The effect of heparin on fibronectin and thrombospondin synthesis and mRNA levels in cultured human endothelial cells. Exp Cell Res. 1990;186:39-46.
12. Varani J, Riser BL, Hughes LA, Carey TE, Fligiel SE, Dixit VM. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin Exp Metastasis. 1989;7:265-276.
13. Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P. Thrombospondin, synthesis and secretion by cells in culture. J Cell Biol. 1982;95:351-354.
14. Sage H, Pritzl P, Bornstein P. Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium. Arteriosclerosis. 1981;1:427-442.
15. Tuszynski GP, Rothman V, Murphy A, et al. Thrombospondin promotes cell-substratum adhesion. Science. 1987;236:1570-1573.
16. Wang TN, Qian X, Granick MS, et al. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J Surg Res 1996;63:39-43.
17. Lahav J. Thrombospondin inhibits adhesion of endothelial cells. Exp Cell Res 1988;177:199-204.
18. Vogel T, Guo NH, Krutzsch HC, et al. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem. 1993;53:74-84.
19. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol. 1990;111:765-772.
20. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol. 1993;122:497-511.
21. Hsu SC, Volpert OV, Steck PA, et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 1996;56:5684-5691.
22. Campbell SC, Volpert OV, Ivanovich M, Bouck NP. Molecular mediators of angiogenesis in bladder cancer. Cancer Res 1998;58: 1298-1304.
23. Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP. Thrombospondin-1 modulates angiogenesis in vivo by up-regulation of matrix metalloproteinase-9 endothelial cells. Exp Cell Res. 1997; 255:403-412.
24. BenEzra D, Griffin BW, Maftzir G, Aharonov O. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci. 1993;34:3601-3608.
25. He S, Hofman F, Lopez P, Ryan SJ, Hinton, DR. Thrombospondin-1 localization in human retina and choroidal neovascular membranes [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4): S353. Abstract nr 1646.
26. Weller M, Esser P, Bresgen M, Heimann K, Wiedemann P. Thrombospondin: a new attachment protein in preretinal traction membranes. Eur J Ophthalmol. 1992;2:10-14.
27. Hiscott P, Larkin G, Robey HL, Orr G, Grierson I. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin. Eye. 1992;6: 566-569.
28. Ishibashi T, Patterson R, Ohnishi Y, Inoniata H, Ryan SJ. Formation of drusen in the human eye. Am J Ophthalmol. 1986;101:342-353.
29. Ryan SJ. The development of an experimental model of subretinal neovascularizution in disciform macular degeneration. Trans Am Ophthalmol Soc. 1979;77:707-745.
30. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206-217.
31. Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol. 1976;60:324-341.
32. Flood MT, Gouras P, Kjeldbye H. Growth characteristics and ultrastructure of human retinal pigment epithelium in vivo. Invest Ophthalmol Vis Sci. 1980;19:1309-1320.
33. Suchard SJ, Mansfield PJ, Dixit VM. Modulation of thrombospondin receptor expression during HL60 cell differentiation. J Immunol. 1994;152:877-888.
34. Touhami A, Fauvel LF, Da Silva N, Chomienne C, Legrand C. Induction of thrombospondin-1 by all-trans retinoic acid modulates growth and differentiation of HL60 mycloid leukemia cells. Leukemia. 1997;11:2137-2142.
35. Lafeuillade B, Pellerin S, Keramidas M, Danik M, Chambaz EM, Feige JJ. Opposite regulation of thrombospondin-1 and corticotropin-induced secreted protein/thrombospondin-2 expression by adrenocorticotropic hormone in adrenocortical cells. J Cell Physiol. 1996;167:164-172.
36. Clezardin P, McGregorJL, Lyon M, Clemetson KJ, Huppert J. Characterization of two murine monoclonal antibodies (p10,p12) directed against different determinants on human blood platelet thrombosponsin. Eur J Biochem. 1986;154:95-102.
37. Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperptatic, and neoplastic human breast. Cancer Res. 1993;53:1421-1430.
38. Qabar A, Derick L, Lawler J, Dixit V. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J Biol Chem. 1995;270:12725-12729.
39. Sedlmayr P, Grosshaupt B, Muntean W. Flow cytometric detection of intracellular platelet antigens. Cytometry. 1996;23:284-289.
40. Hiscott P, Seitz H, Schlotzer SU, Naumannn GOH. Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea. Cell Tissue Res. 1997;289:307-310.
41. Klintworth GK. Corneal avascularity and vascularity. In: Corneal angiogenesis: a comprehensive critical review. New York: Springer-Verlag; 1990 1-3.
42. Frazier WA, Prater CA, Jaye D, Kosfeld MD. Interactions of thrombospondin with cells. In: Lahav J. ed Thrombospondin. Boca Raton, FL: CRC Press; 1993:91-109.
43. Loganadane LD, Berge N, Legrand C, Fauvel Lafeve F. Endothelial cell proliferation regulated by cytokines modulates thrombospondin-1 secretion into the subendothelium. Cytokine. 1997; 9:740-746.
44. Frater Schroder M, Muller G, Birchmeier W, Bohlen P. Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun. 1986;137:295-302.
45. Heimark RL, Twardzik DR, Schwartz SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science. 1986;233:1078-1080.
46. Murphy Ullrich JE, Schultz Cherry S, Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell. 1992;3:181-188.
47. Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci. 1986;27:1615-1621.
48. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol. 1995;130: 503-506.
49. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retina Eye Res. 1999;18:167-190.
50. Mousa SA, Lorelli W, Campochiaro PA. Role of hypoxia and extra-cellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigment epithelial cells. J Cell Biol. 1999;74:135-143.
51. Pellerin S, Lafeuillade B, Chambaz EM, Feige JJ. Distinct effects of thrombospondin-1 and CISP/thrombospondin-2 on adrenocortical cell spreading. Mol Cell Endocrinol. 1994;106:181-186.
52. Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 1996;10:1183-1191.
53. Frenzel EM, Neely KA, Walsb AW, Cameron JD, Gregerson DS. Vitronectin and thrombospondin promote retinal neurite outgrowth: developmental regulation and role of integrins. Neuron. 1991;6:345-358.
54. Mumby SM, Abbott Brown D, Raugi GJ, Bornstein P. Regulation of thrombospondin secretion by cells in culture. J Cell Physiol 1984; 120:280-288.
55. Sherwood JA. Molecular pathology, cell attachment, and the potential role of thrombospondin in malaria. In: Lahav J, ed. Thrombospondin. Boca Raton, FL: CRC Press: 1993:227-257.
56. Dawson DW, Pearce SFA, Zhong R, Silverstein RL, Frazier WA, Houck NP. CD36 Mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 1997;138: 707-717.
57. Daviet L, Craig AG, McGregor L, et al. Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. Eur J Biochem. 1997;243:344-349.
58. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediatiors. Arterioscler Thromb Vasc Biol. 1996;16:1019-1025.
59. Ryeom SW, Sparrow JR, Silverstein RL. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci. 1996;109:387-395.